Merck & Co Inc logo

Merck & Co Inc

NEW
NYSE:MRK (USA)  
$ 126.26 +1.86 (+1.5%) 10:08 PM EST
35.57
P/B:
6.80
Market Cap:
$ 311.84B
Enterprise V:
$ 355.31B
Volume:
7.22M
Avg Vol (2M):
11.27M
Trade In:
Volume:
7.22M
Avg Vol (2M):
11.27M
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PS Ratio for MRK ( Merck & Co Inc ) from 1990 to Jul 22 2026. The price to sales ratio is calculated by taking the current stock price and dividing it by the trailing twelve-month sales per share. The data is updated every 20 minutes during market hours. The PS ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS ratio is a great valuation tool for evaluating cyclical businesses where the PE ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean. Merck & stock (MRK) PS ratio as of Jul 22 2026 is 4.78. More Details

Merck & Co Inc (MRK) PS Ratio Chart

To

Merck & Co Inc (MRK) PS Ratio Historical Data

Total 1208
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Merck & PS Ratio Historical Data
Date PS Ratio Data Date PS Ratio Data
2026-07-22 4.7 4.8 4.7 4.78 2026-05-15 4.3 4.32 4.2 4.22
2026-07-21 4.7 4.8 4.7 4.78 2026-05-14 4.3 4.31 4.26 4.3
2026-07-20 4.8 4.84 4.71 4.71 2026-05-13 4.3 4.32 4.24 4.3
2026-07-17 4.9 4.99 4.81 4.83 2026-05-12 4.2 4.31 4.22 4.26
2026-07-16 4.7 4.88 4.7 4.83 2026-05-11 4.3 4.31 4.2 4.22
2026-07-15 4.7 4.73 4.65 4.68 2026-05-08 4.3 4.28 4.21 4.22
2026-07-14 4.7 4.68 4.55 4.58 2026-05-07 4.3 4.31 4.21 4.25
2026-07-13 4.7 4.73 4.64 4.7 2026-05-06 4.3 4.34 4.27 4.3
2026-07-10 4.7 4.76 4.66 4.68 2026-05-05 4.3 4.32 4.27 4.29
2026-07-09 4.8 4.85 4.71 4.74 2026-05-04 4.2 4.34 4.2 4.28
2026-07-08 4.9 4.89 4.74 4.77 2026-05-01 4.3 4.34 4.24 4.25
2026-07-07 4.9 4.91 4.84 4.88 2026-04-30 4.1 4.25 4.11 4.14
2026-07-06 4.9 4.92 4.76 4.8 2026-04-29 4.1 4.21 4.09 4.2
2026-07-02 4.8 4.91 4.77 4.91 2026-04-28 4.2 4.24 4.16 4.17
2026-07-01 4.8 4.86 4.72 4.75 2026-04-27 4.2 4.27 4.17 4.18
2026-06-30 4.9 4.94 4.8 4.87 2026-04-24 4.3 4.32 4.22 4.24
2026-06-29 4.8 4.92 4.8 4.9 2026-04-23 4.3 4.36 4.28 4.34
2026-06-26 4.8 4.88 4.77 4.87 2026-04-22 4.3 4.3 4.23 4.28
2026-06-25 4.6 4.77 4.58 4.75 2026-04-21 4.4 4.41 4.24 4.26
2026-06-24 4.6 4.61 4.53 4.57 2026-04-20 4.5 4.52 4.42 4.44
2026-06-23 4.4 4.54 4.41 4.53 2026-04-17 4.4 4.52 4.38 4.51
2026-06-22 4.3 4.38 4.28 4.37 2026-04-16 4.4 4.46 4.35 4.37
2026-06-18 4.3 4.35 4.23 4.31 2026-04-15 4.5 4.55 4.42 4.47
2026-06-17 4.3 4.39 4.32 4.37 2026-04-14 4.5 4.56 4.48 4.54
2026-06-16 4.4 4.39 4.3 4.36 2026-04-13 4.6 4.59 4.51 4.55
2026-06-15 4.5 4.51 4.35 4.35 2026-04-10 4.7 4.66 4.58 4.6
2026-06-12 4.6 4.62 4.5 4.51 2026-04-09 4.7 4.7 4.6 4.65
2026-06-11 4.5 4.65 4.54 4.57 2026-04-08 4.5 4.68 4.47 4.67
2026-06-10 4.5 4.55 4.44 4.51 2026-04-07 4.5 4.53 4.41 4.52
2026-06-09 4.5 4.56 4.47 4.53 2026-04-06 4.6 4.6 4.55 4.58
2026-06-08 4.6 4.64 4.5 4.53 2026-04-02 4.6 4.61 4.52 4.58
2026-06-05 4.6 4.68 4.56 4.58 2026-04-01 4.6 4.63 4.56 4.58
2026-06-04 4.4 4.57 4.44 4.56 2026-03-31 4.5 4.59 4.5 4.56
2026-06-03 4.4 4.44 4.34 4.34 2026-03-30 4.6 4.61 4.44 4.47
2026-06-02 4.3 4.42 4.34 4.38 2026-03-27 4.6 4.67 4.57 4.61
2026-06-01 4.5 4.47 4.33 4.36 2026-03-26 4.6 4.63 4.57 4.58
2026-05-29 4.5 4.57 4.48 4.5 2026-03-25 4.5 4.63 4.5 4.6
2026-05-28 4.6 4.6 4.52 4.54 2026-03-24 4.4 4.49 4.39 4.48
2026-05-27 4.5 4.64 4.54 4.55 2026-03-23 4.5 4.49 4.42 4.46
2026-05-26 4.7 4.66 4.52 4.53 2026-03-20 4.4 4.44 4.34 4.4
2026-05-22 4.6 4.65 4.55 4.64 2026-03-19 4.4 4.46 4.38 4.4
2026-05-21 4.3 4.39 4.25 4.39 2026-03-18 4.4 4.45 4.37 4.41
2026-05-20 4.3 4.35 4.28 4.28 2026-03-17 4.5 4.5 4.41 4.47
2026-05-19 4.3 4.36 4.25 4.33 2026-03-16 4.4 4.47 4.4 4.45
2026-05-18 4.2 4.28 4.2 4.26 2026-03-13 4.5 4.54 4.45 4.46

Merck & Co Inc (MRK) PS Ratio Comparison

Company Market Cap(Mil) PS Ratio

Business Description

Business Description

Description
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).